Safer Prescribing of Controlled Substances Act
Legislative Progress
Introduced
November 3, 2015
Latest Action
December 4, 2015
Primary Sponsor
Yvette D. ClarkeDemocratic(NY)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
68pct
31d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Safer Prescribing of Controlled Substances Act This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration, as a condition of granting or renewing the registration of a covered practitioner to dispense, or conduct research with, controlled substances in schedule II, III, IV, or V, to require such practitioner to complete training that the Department of Health and Human Services (HHS) determines meets the requirements of this bill. It defines a "covered practitioner" as a practitioner that is not a hospital, pharmacy, or veterinarian. It requires such training to expose covered practitioners to: best practices for pain management, including alternatives to prescribing controlled substances; responsible prescribing of pain medications; methods for diagnosing, treating, and managing a substance use disorder, including evidence-based nonpharmacological therapies; ways of linking patients to evidence-based treatment for substance use disorders; and tools to manage adherence and diversion of controlled substances. The Substance Abuse and Mental Health Services Administration must establish or support the establishment of at least one free, online training module that meets such requirements to be provided to any covered practitioner registered or applying for registration. The bill requires HHS: (1) to establish, maintain, and periodically update a publicly available database providing information on such training modules; and (2) within five years after enactment of this bill, to evaluate and make publicly available a report describing how exposure to training required by this bill has changed prescribing patterns of controlled substances.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2016 · second_quarter · Health Issues
S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act; S.1392/H.R. 3889 - Safer Prescribing of Controlled Substances Act; H.R. 4586 - Lalis Law; H.R. 4969 - John Thomas Decker Act; S. 1641 - Jason Simcakoski Memorial Opioid Safety Act; S.2256 - Co-Prescribing Saves Lives Act of 2015; prescription drug monitoring programs; drug testing programs; opioid prescribing guidelines; opioid abuse treatment; prescription drug overdose prevention in general; injury prevention in general
Client expense: $6,000 · Firm income: Not reported
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress.gov source codes: H11100, H11100-A
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Centers For Disease Control & Prevention (CDC), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Occupational Safety & Health Administration (OSHA), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)
2016 · first_quarter · Health Issues
S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act; S.1392/H.R. 3889 - Safer Prescribing of Controlled Substances Act; H.R. 4586 - Lalis Law; S.2256 - Co-Prescribing Saves Lives Act of 2015; prescription drug monitoring programs; drug testing programs; opioid prescribing guidelines; opioid abuse treatment; prescription drug overdose prevention in general; injury prevention in general
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Highway Traffic Safety Administration (NHTSA), Occupational Safety & Health Administration (OSHA), Office of Natl Drug Control Policy (NDCP), SENATE, Small Business Administration (SBA), Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)
2015 · fourth_quarter · Health Issues
S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act; prescription drug monitoring programs; S. 707/H.R. 1821 - Opioid Overdose Reduction Act; S.1392/H.R. 3889 - Safer Prescribing of Controlled Substances Act; drug testing programs; opioid prescribing guidelines; prescription drug overdose prevention in general; injury prevention in general
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Highway Traffic Safety Administration (NHTSA), Natl Transportation Safety Board (NTSB), Occupational Safety & Health Administration (OSHA), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)